Transcept Pharmaceuticals Inc.’s (TSPT) share price has entered into oversold territory with a stochastic value of 3.3220. The Zacks Consensus Estimate on the company’s loss for year ending December 2012 decreased by 4 cents over the past two months to a loss of 71 cents per share. Transcept Pharmaceuticals Inc. is a Zacks #2 Rank (“Buy”) company.
TRANSCEPT PHARMACEUTICALS INC (TSPT): Free Stock Analysis Report
More From Zacks.com
